- Telehealth Visits
Phillip Moore, MD
Pediatric CardiologyOn this page
About me
Dr. Phillip Moore is a cardiologist who specializes in treating congenital heart disease.
Moore directs UCSF's pediatric cardiac catheterization laboratory. He is active in developing and testing new catheter-based devices and procedures (using the small tubes called catheters, which can enter blood vessels and reach the heart, to diagnose and treat heart conditions).
Moore earned his medical degree from the University of California, San Diego. He completed a residency in pediatrics at the University of Washington Medical Center. He completed a fellowship in pediatric cardiology at UCSF.
Moore is internationally known for his work on patent ductus arteriosus (a congenital heart defect) and atrial septal defect device closure (an implant that can correct a hole in the wall between the heart's upper chambers). He is also known for his work on using magnetic resonance imaging to guide catheter-based treatments of congenital heart disease.
Education
Board Certification
- Adult Congenital Heart Disease, American Board of Internal Medicine
- Pediatric Cardiology, American Board of Pediatrics
Fellowship
- Pediatric Cardiology, UCSF School of Medicine -GME
Residency
- Pediatrics, University of Washington School of Medicine
Internship
- Pediatrics, University of Washington School of Medicine
School
- MD, University of California San Diego School of Medicine
Academic Title
- Clinical Professor
Care Keywords
Services
- Pediatric Cardiology
Locations
Provider Research Listing
Browse clinical trials and publications by this provider
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.